[Efficacy and safety of bempedoic acid in the prevention of cardiovascular events: results of the CLEAR Outcomes study and subgroup analyses] [0.03%]
苯乙双胍预防心血管事件的疗效和安全性——CLEAR Outcomes研究及亚组分析结果
Furio Colivicchi,Marcello Arca,Stefania Angela Di Fusco et al.
Furio Colivicchi et al.
Bempedoic acid is a lipid-lowering drug recently introduced into clinical practice. The CLEAR Outcomes randomized controlled clinical trial has confirmed the efficacy of bempedoic acid in reducing low-density lipoprotein cholesterol (LDL-C)...
[Cardiovascular disease in adult cancer survivors: a new frontier for cardio-oncology] [0.03%]
成人癌症幸存者的心血管疾病：心身医学的新前沿
Andrea Tedeschi,Maria Laura Canale,Alessandra Greco et al.
Andrea Tedeschi et al.
The enormous progress made in recent decades in the diagnosis and treatment of oncological and hematological diseases has resulted in a significant increase in patient survival and a substantial growth in the population of cancer survivors....
[Ten questions about the athlete's heart: a guide for the clinical cardiologist] [0.03%]
[关于运动员心脏的十个问题——临床心脏病学家指南]
Francesca Musella,Giuseppe Ciliberti,Federico Fortuni et al.
Francesca Musella et al.
The athlete's heart is a complex physiological adaptation to sustained physical training, necessitating a specialized approach to diagnosis and management. Advanced cardiac imaging plays a pivotal role in differentiating physiological remod...
Luigi Tavazzi
Luigi Tavazzi
Riccardo Scagliola,Manrico Balbi,Claudio Brunelli
Riccardo Scagliola
[The top ten novelties of the ESC guidelines for the management of myocarditis and pericarditis] [0.03%]
2022年欧洲心肌炎和心包炎管理指南十大新颖之处
Massimo Imazio,Attilio Iacovoni
Massimo Imazio
[Flu vaccination in cardiovascular prevention: a low-cost therapy to be implemented] [0.03%]
心血管病预防中流感疫苗接种的实施——一种低成本高效益的策略
Giuseppe Di Pasquale
Giuseppe Di Pasquale
[A heart-pounding match] [0.03%]
一场惊心动魄的比赛！
Maria Mele,Elisabetta Tonet
Maria Mele
[ANMCO Position paper: ANMCO States General 2024 - In the era of precision cardiology, a reflection on the balance between cost containment and innovation] [0.03%]
[ANMCO 委员会论文：2024 年 ANMCO 全体会议 - 精准心脏病学时代的精准心脏病学时代，关于成本控制与创新之间平衡的思考]
Giovanna Geraci,Attilio Iacovoni,Fabiana Lucà et al.
Giovanna Geraci et al.
Cardiovascular diseases continue to be the leading cause of death worldwide, with ischemic heart disease remaining the primary cause among cardiovascular conditions; as is well known, it is closely linked to LDL cholesterol levels, now iden...